In this instalment of ‘The Small Print’, Dr Param Shah, Director (UK) FICCI deciphers what Brexit negotiations mean for Indian start-ups with an eye on the UK market.
The Indian pharmaceutical industry is seeking to move up the global pharmaceutical value chain by investing into R&D for drug development. Given the UK’s strengths in this area it stands out as the perfect partner of choice.
Several upcoming entrepreneurs are working to help India achieve balanced regional development by creating social impact-driven business models having a double bottom line, and while doing so, address the commercial market demands with a purpose-driven leadership at its base.
With the new entry of Razorpay, technological innovation and adaptation in India, across an array of sectors, has ensured the rapid upsurge of six unicorns across diverse platforms that are ambitious and aggressive.
techXchange is a platform that will act as a bridge between the demand and supply of innovative technologies between India and the UK.
Gender is no longer a barrier to be a unicorn, or a simple start-up to begin with. All one needs is the will, the dedication, and the right strategy which helps them to soar to great heights.